Skip to main content

Table 1 Clinical features in READ patients

From: A glycolysis-related two-gene risk model that can effectively predict the prognosis of patients with rectal cancer

Variables

Patients, n (%)

Sex

 

 Male

77 (54.2%)

 Female

65 (45.8%)

Age, years

 

 ≤ 65

73 (51.4%)

 > 65

69 (48.6%)

TNM stage

 

 I

26 (18.3%)

 II

41 (28.9%)

 III

45 (31.7%)

 IV

22 (15.5%)

 Unknown

8 (5.6%)

T stage

 

 T1

7 (4.9%)

 T2

25 (17.6%)

 T3

98 (69.0%)

 T4

11 (7.8%)

 Unknown

1 (0.7%)

N stage

 

 N0

70 (49.2%)

 N1

40 (28.2%)

 N2

29 (20.4%)

 N3

0 (0.0%)

 NX

2 (1.4%)

 Unknown

1 (0.7%)

M stage

 

 M0

106 (74.6%)

 M1

21 (14.9%)

 MX

13 (9.1%)

 Unknown

2 (1.4%)

Follow up time

 

 = 0 day or unknown

7 (4.9%)

 > 0 day

135 (95.1%)